Clinical trials: Active control vs placebo - What is ethical?

Science and Engineering Ethics

Volumn 10, Issue 1, 2004, Pages 73-79

  Spławiński, Jacek ^a   Kuźniar, Jerzy ^b  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b District Hospital No 2   (Poland)

Author keywords

Active control; Informed consent; Non inferiority; Placebo; Superiority; Uncertainty principle

Indexed keywords

ANTIARRHYTHMIC AGENT; ESTROGEN; GESTAGEN; NEW DRUG; PLACEBO;

CLINICAL TRIAL; CONFERENCE PAPER; CONFIDENCE INTERVAL; DEPRESSION; DRUG EFFICACY; HEART ARRHYTHMIA; HORMONE SUBSTITUTION; HUMAN; HYPOTHESIS; INFORMED CONSENT; MEDICAL ETHICS; RANDOMIZATION;

EID: 1242351870     PISSN: 13533452     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11948-004-0065-x     Document Type: Conference Paper

References (16)

1. Hrobjartsson, A. & Gøtzsche, P.C. (2001) Is placebo powerless? The New England Journal of Medicine 344: 1594-1602.
2. Berkowitz, B.A. & Katzung, B.G. (2001) Basic & Clinical evaluation of new drugs, in: Katzung, B.G. ed. Basic & Clinical Pharmacology. Lange Medical Books/McGraw-Hill, New York: 64-74.
3. Szumowski, W. Historia Medycyny. Gebethner i Wolf, Kraków, 1935.
4. Holy Bible Genesis XXIII.16.
5. Aras, G (2001) Superiority, noninferiority, equivalence, and bioequivalence - revisited. Drug Information Journal 35: 1157-1164.
6. Emanuel, E.J. & Miller, F.G. (2001) The ethics of placebo-controlled trials - a middle ground. The New England Journal of Medicine 345: 915-919.
7. Temple, R. & Ellenberg, S.S. (2000) Placebo controlled trials and active-control trials in the evaluation of new treatments. Part 1: Ethical and scientific issues. Annals of Internal Medicine 133: 455-463.
8. Rothman, K.J. & Michelis, K.B. (1994) The continuing unethical use of placebo controls. The New England Journal of Medicine 331: 394-398.
9. Rudowski, W. (1980) World Health Organization Biomedical Research Guidelines and the Conduct of Clinical Trials. Journal of Medical Ethics: 58-66.
10. The CAST Investigators (1989) Preliminary report: effect of encainide and flecainide on mortality in randomized trial of arrhythmia suppression after myocardial infarction. The New England Journal of Medicine 321: 406-412.
11. Hulley, S., Grady, D., Bush, T., Furberg, C., Riggs, B. & Hulley, S. (1989) Randomized trial of estrogen plus progestin for secondary prevention of coronary artery disease in women. Journal of American Medical Association 280: 605-611.
12. Ling, Y.-L., Chern, H.-D., Chu, M.-L. (2002) Placebo controlled clinical trials are as ethical as active controlled trials even if effective therapies exist. Drug Information Journal 36: 739-741.
13. Green, B.M., Taylor, H.R., Cupp, E.W., Murphy, R.P., White, A.T., Aziz, M.A., Schulz-Key, H., D'Anna, S., Newland, H.S., Goldschmidt, L.P., Auer, C., Hansos, A.P., Freeman, S.V., Reber, E.W., Williams, N.P. (1985) Comparison of ivermectin and diethylcarbamazine in treatment of onchocerciasis. The New England Journal of Medicine 313: 133-138.
14. Mason, J.K. & McCall Smith, R.A. (1994) Law and Medical Ethics. Butterworths, London, Dublin, Edinburgh.
15. Scrip (2003) No. 2827: 20.
16. Koch, A. & Rohmel, J. (2002) The impact of sloppy study to conduct on noninferiority studies. Drug Information Journal 36: 3-6.